Italian hospital

First Volunteer Receives Italian Anti-COVID-19 Vaccine

First Volunteer Receives Italian Anti-COVID-19 Vaccine

An Italian hospital said on Monday it had inoculated a first volunteer with an anti-COVID-19 vaccine as part of human trials expected to last six months.

The woman, in her 50s, received the first dose developed by Rome-based biotech company ReiThera at the capital’s Spallanzani Institute for infectious diseases.

The trials, developed between ReiThera and Spallanzani researchers, will be carried out on 90 volunteers divided into groups by age to test the efficacy of different dosages of the vaccine, developed since March.

If the first results of Phase 1 of the human trials prove positive, researchers say they will be …